BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21039478)

  • 21. Neuroendocrine regulatory peptide-1 and -2: novel bioactive peptides processed from VGF.
    Toshinai K; Nakazato M
    Cell Mol Life Sci; 2009 Jun; 66(11-12):1939-45. PubMed ID: 19194657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VGF: an inducible gene product, precursor of a diverse array of neuro-endocrine peptides and tissue-specific disease biomarkers.
    Ferri GL; Noli B; Brancia C; D'Amato F; Cocco C
    J Chem Neuroanat; 2011 Dec; 42(4):249-61. PubMed ID: 21621608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases.
    Marin R; Fabelo N; Martín V; Garcia-Esparcia P; Ferrer I; Quinto-Alemany D; Díaz M
    Neurobiol Aging; 2017 Jan; 49():52-59. PubMed ID: 27768960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a receptor for neuropeptide VGF and its role in neuropathic pain.
    Chen YC; Pristerá A; Ayub M; Swanwick RS; Karu K; Hamada Y; Rice AS; Okuse K
    J Biol Chem; 2013 Nov; 288(48):34638-46. PubMed ID: 24106277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of VGF- and pro-SAAS-derived peptides in endocrine tissues and the brain, and their regulation by diet and cold stress.
    Chakraborty TR; Tkalych O; Nanno D; Garcia AL; Devi LA; Salton SR
    Brain Res; 2006 May; 1089(1):21-32. PubMed ID: 16631141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM; Schulz P; Sierks MR
    Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Environmental radon daughters reveal pathognomonic changes in the brain proteins and lipids in patients with Alzheimer's disease and Parkinson's disease, and cigarette smokers.
    Momcilović B; Alkhatib HA; Duerre JA; Cooley MA; Long WM; Harris RT; Lykken GI
    Arh Hig Rada Toksikol; 1999 Dec; 50(4):347-69. PubMed ID: 10851740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An increase in VGF expression through a rapid, transcription-independent, autofeedback mechanism improves cognitive function.
    Lin WJ; Zhao Y; Li Z; Zheng S; Zou JL; Warren NA; Bali P; Wu J; Xing M; Jiang C; Tang Y; Salton SR; Ye X
    Transl Psychiatry; 2021 Jul; 11(1):383. PubMed ID: 34238925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat gastric motor functions.
    Severini C; La Corte G; Improta G; Broccardo M; Agostini S; Petrella C; Sibilia V; Pagani F; Guidobono F; Bulgarelli I; Ferri GL; Brancia C; Rinaldi AM; Levi A; Possenti R
    Br J Pharmacol; 2009 Jul; 157(6):984-93. PubMed ID: 19466987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Could VGF and/or its derived peptide act as biomarkers for the diagnosis of neurodegenerative diseases: A systematic review.
    Alqarni S; Alsebai M
    Front Endocrinol (Lausanne); 2022; 13():1032192. PubMed ID: 36619561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The VGF-derived peptide TLQP-21: a new modulatory peptide for inflammatory pain.
    Rizzi R; Bartolomucci A; Moles A; D'Amato F; Sacerdote P; Levi A; La Corte G; Ciotti MT; Possenti R; Pavone F
    Neurosci Lett; 2008 Aug; 441(1):129-33. PubMed ID: 18586396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropeptides in neurological disease.
    Beal MF; Martin JB
    Ann Neurol; 1986 Nov; 20(5):547-65. PubMed ID: 2947536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implication of the VGF-derived peptide TLQP-21 in mouse acute and chronic stress responses.
    Razzoli M; Bo E; Pascucci T; Pavone F; D'Amato FR; Cero C; Sanghez V; Dadomo H; Palanza P; Parmigiani S; Ceresini G; Puglisi-Allegra S; Porta M; Panzica GC; Moles A; Possenti R; Bartolomucci A
    Behav Brain Res; 2012 Apr; 229(2):333-9. PubMed ID: 22289198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease.
    Langston JW; Sastry S; Chan P; Forno LS; Bolin LM; Di Monte DA
    Exp Neurol; 1998 Dec; 154(2):684-90. PubMed ID: 9878203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the reproductive effects of the anorexigenic VGF-derived peptide TLQP-21: in vivo and in vitro studies in male rats.
    Pinilla L; Pineda R; Gaytán F; Romero M; García-Galiano D; Sánchez-Garrido MA; Ruiz-Pino F; Tena-Sempere M; Aguilar E
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E837-47. PubMed ID: 21304062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein.
    Savage MJ; Iqbal M; Loh T; Trusko SP; Scott R; Siman R
    Neuroscience; 1994 Jun; 60(3):607-19. PubMed ID: 7936190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vgf is a novel biomarker associated with muscle weakness in amyotrophic lateral sclerosis (ALS), with a potential role in disease pathogenesis.
    Zhao Z; Lange DJ; Ho L; Bonini S; Shao B; Salton SR; Thomas S; Pasinetti GM
    Int J Med Sci; 2008 Apr; 5(2):92-9. PubMed ID: 18432310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes.
    Beal MF; Mazurek MF; Martin JB
    Brain Res; 1986 Nov; 397(2):386-8. PubMed ID: 3801878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concentrations of several proteins characteristic of nervous tissue in cerebral cortex of patients with Alzheimer's disease.
    Kato K; Kurobe N; Suzuki F; Morishita R; Asano T; Sato T; Inagaki T
    J Mol Neurosci; 1991; 3(2):95-9. PubMed ID: 1814396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced density of hypothalamic VGF-immunoreactive neurons in schizophrenia: a potential link to impaired growth factor signaling and energy homeostasis.
    Busse S; Bernstein HG; Busse M; Bielau H; Brisch R; Mawrin C; Müller S; Sarnyai Z; Gos T; Bogerts B; Steiner J
    Eur Arch Psychiatry Clin Neurosci; 2012 Aug; 262(5):365-74. PubMed ID: 22167530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.